default author photo

Mioara Larion

National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch

Bethesda, MD

United States

SCHOLARLY PAPERS

1

DOWNLOADS

92

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Metabolic Plasticity of IDH1- Mutant Glioma Cell Lines Is Responsible for Low Sensitivity to Glutaminase Inhibition

Number of pages: 36 Posted: 17 May 2019
National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, National Cancer Institute at Frederick, Center for Cancer Research, Structural Biophysics Laboratory, National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch, Heidelberg University - Division of Neurosurgical Research, National Cancer Institute at Frederick - Structural Biophysics Laboratory, Government of the United States of America - Neuro-Oncology Branch and National Institutes of Health (NIH), National Cancer Institute, Neuro-Oncology Branch
Downloads 92 (736,406)
Citation 1

Abstract:

Loading...

IDH1-mutant, gliomas, glutaminase, CB839, AGI5198, 13C tracing